
FDA Approves a Daily Pill as a First Treatment for Two Blood Cancers
The Food and Drug Administration approved the pill pirtobrutinib on Oct. 2, 2026, as a first treatment for two blood cancers, chronic lymphocytic leukemia and small lymphocytic lymphoma. The approval…










